Consolidated Statement Of Profit Or Loss

Solasia Pharma K.K. - Filing #7272454

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Consolidated statement of profit or loss
Statement of profit or loss
Revenue
316,000,000 JPY
617,000,000 JPY
Cost of sales
131,000,000 JPY
280,000,000 JPY
Gross profit
185,000,000 JPY
337,000,000 JPY
Selling, general and administrative expenses
1,721,000,000 JPY
1,073,000,000 JPY
Other income
JPY
0 JPY
Other expenses
0 JPY
JPY
Operating profit (loss)
-1,951,000,000 JPY
-1,139,000,000 JPY
Finance income
0 JPY
10,000,000 JPY
Finance costs
5,000,000 JPY
0 JPY
Share of profit (loss) of investments accounted for using equity method
-4,000,000 JPY
-5,000,000 JPY
Profit (loss) before tax
-1,961,000,000 JPY
-1,135,000,000 JPY
Income tax expense
-19,000,000 JPY
-22,000,000 JPY
Profit (loss)
JPY
-1,941,000,000 JPY
JPY
JPY
-1,941,000,000 JPY
JPY
JPY
JPY
JPY
-1,112,000,000 JPY
JPY
JPY
-1,112,000,000 JPY
JPY
JPY
JPY
Profit (loss) attributable to
Owners of parent
-1,941,000,000 JPY
-1,112,000,000 JPY
Earnings (loss) per share
Basic earnings (loss) per share
-9.77
-6.62
Diluted earnings (loss) per share
-9.77
-6.62

Talk to a Data Expert

Have a question? We'll get back to you promptly.